CSIMarket
 


Mylan N v   (MYL)
Other Ticker:  
 
 

MYL's Net Cash Flow Growth by Quarter and Year

Mylan N V 's Net Cash Flow results by quarter and year




MYL Net Cash Flow (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December - 101.80 - -322.80
III Quarter September 342.40 - - -108.90
II Quarter June -263.20 - - -275.00
I Quarter March 96.80 - - -257.80
FY   176.00 101.80 - -964.50



MYL Net Cash Flow third quarter 2020 Y/Y Growth Comment
Mylan N v in the third quarter achieved Net Cash Flow of $ 342.40 millions compare to net cash outflow recorded in same quarter a year ago.

According to the results reported in the third quarter, Mylan N V achieved the best Net Cash Flow growth in Major Pharmaceutical Preparations industry. While Mylan N V ' s Net Cash Flow no change of % ranks overall at the positon no. 0 in the third quarter.




MYL Net Cash Flow ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Mylan N V 's third quarter 2020 Net Cash Flow $ 342.40 millions MYL's Income Statement
Mylan N V 's third quarter 2019 Net Cash Flow $ 0.00 millions Quarterly MYL's Income Statement
New: More MYL's historic Net Cash Flow Growth >>


MYL Net Cash Flow (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March -4.91 % - - -
FY (Year on Year)   - - - -




Net Cash Flow third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #0

Net Cash Flow Y/Y Growth Statistics
High Average Low
8795.5 % 1041.47 % -100 %
(March 31 2007)   (Dec 31 2011)
Net Cash Flow third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #0
Net Cash Flow Y/Y Growth Statistics
High Average Low
8795.5 % 1041.47 % -100 %
(March 31 2007)   (Dec 31 2011)

Net Cash Flow by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Mylan N V 's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
1315.4 % 145.56 % -94.27 %
(Dec. 31. 2006)  


MYL's III. Quarter Q/Q Net Cash Flow Comment
This turnaround III. Quarter 2020where Mylan N v posted Net Cash Flow of $ 342.40 millions could is starting point of better business climet.Mylan N v announced in the III. Quarter 2020 Net Cash Flow of $ 342.40 millions compare to net cash outflow recorded in previos quarter.

Within Major Pharmaceutical Preparations industry Mylan N v achieved highest sequential Net Cash Flow growth. While Mylan N V 's Net Cash Flow growth quarter on quarter, overall rank is 0.


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #0
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #0
Net Cash Flow Q/Q Growth Statistics
High Average Low
1315.4 % 145.56 % -94.27 %
(Dec. 31. 2006)  


MYL's III. Quarter Q/Q Net Cash Flow Comment
Improvement III. Quarter 2020where Mylan N v published Net Cash Flow of $ 342.40 millions should be inception of improved business climet.Mylan N v announced in the III. Quarter 2020 Net Cash Flow of $ 342.40 millions compare to net cash outflow recorded in previos quarter.

Within Major Pharmaceutical Preparations industry Mylan N v achieved highest sequential Net Cash Flow growth. While Mylan N V 's Net Cash Flow growth quarter on quarter, overall rank is 0.


Mylan N V 's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
Cumulative Net Cash Flow 12 Months Ending $ 277.80 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Net Cash Flow Growth (TTM) - - - - -
Year on Year Net Cash Flow Growth Overall Ranking # # # # #
Seqeuential Net Cash Flow Change (TTM) - - - - -
Seq. Net Cash Flow Growth (TTM) Overall Ranking # # # # #




Cumulative Net Cash Flow growth Comment


Mylan N v achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
670.23 %
84.96 %
-90.6 %
(March 31 2007)  

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall # 0

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
3230.69 %
813.43 %
-83.64 %
(June 30, 2010)  


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 # 0
Cumulative Net Cash Flow growth Comment


Mylan N v achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
670.23 %
84.96 %
-90.6 %
(March 31 2007)  


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall # 0

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
3230.69 %
813.43 %
-83.64 %
(June 30, 2010)  


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 # 0




Other Net Cash Flow Growth
Major Pharmaceutical Preparations Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
MYL's Net Cash Flow Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for MYL's Competitors
Net Cash Flow Growth for Mylan N V 's Suppliers
Net Cash Flow Growth for MYL's Customers

You may also want to know
MYL's Annual Growth Rates MYL's Profitability Ratios MYL's Asset Turnover Ratio MYL's Dividend Growth
MYL's Roe MYL's Valuation Ratios MYL's Financial Strength Ratios MYL's Dividend Payout Ratio
MYL's Roa MYL's Inventory Turnover Ratio MYL's Growth Rates MYL's Dividend Comparisons



Companies with similar Net Cash Flow no change for the quarter ending Sep 30 2020 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Sep 30 2020
Reliv International Inc-2.10%$ -2.099 millions
Nu med Plus Inc -6.63%$ -6.627 millions
Gilead Sciences Inc -8.36%$ -8.358 millions
Homology Medicines Inc-10.84%$ -10.839 millions
Utah Medical Products Inc-12.65%$ -12.652 millions
Motus Gi Holdings Inc -16.55%$ -16.546 millions
Novocure Limited-18.11%$ -18.113 millions
Irhythm Technologies Inc -26.37%$ -26.374 millions
Radnet Inc -28.23%$ -28.229 millions
Pacira Biosciences inc -35.85%$ -35.853 millions
Biotelemetry Inc -36.86%$ -36.862 millions
Crispr Therapeutics Ag-38.50%$ -38.505 millions
Innoviva inc -40.25%$ -40.246 millions
Integra Lifesciences Holdings Corp-48.95%$ -48.949 millions
Acadia Pharmaceuticals Inc -54.38%$ -54.376 millions
Seelos Therapeutics Inc -60.62%$ -60.623 millions
Rhythm Pharmaceuticals inc -61.25%$ -61.249 millions
Abbvie Inc -65.80%$ -65.796 millions
Exicure Inc -67.68%$ -67.680 millions
Incyte Corp-68.19%$ -68.194 millions
Edwards Lifesciences Corporation-73.79%$ -73.793 millions
Baxter International Inc -76.77%$ -76.772 millions
Gb Sciences Inc-81.66%$ -81.655 millions
Fulcrum Therapeutics Inc -81.71%$ -81.714 millions
Satsuma Pharmaceuticals Inc -82.90%$ -82.904 millions
Aerpio Pharmaceuticals Inc -83.28%$ -83.277 millions
Grapefruit Usa Inc-83.85%$ -83.850 millions
Exact Sciences Corporation-88.24%$ -88.241 millions
Magenta Therapeutics Inc -89.71%$ -89.707 millions
Encompass Health Corporation-89.98%$ -89.982 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

KRP's Profile

Stock Price

KRP's Financials

Business Description

Fundamentals

Charts & Quotes

KRP's News

Suppliers

KRP's Competitors

Customers & Markets

Economic Indicators

KRP's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071